These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 8980621)

  • 1. Local and systemic antibody levels against protein D of Haemophilus influenzae following immunization and infection in rats.
    Akkoyunlu M; Forsgren A
    APMIS; 1996 Oct; 104(10):709-17. PubMed ID: 8980621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children.
    Khan MN; Kaur R; Pichichero ME
    FEMS Immunol Med Microbiol; 2012 Aug; 65(3):439-47. PubMed ID: 22463053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
    Hotomi M; Ikeda Y; Suzumoto M; Yamauchi K; Green BA; Zlotnick G; Billal DS; Shimada J; Fujihara K; Yamanaka N
    Vaccine; 2005 Jan; 23(10):1294-300. PubMed ID: 15652672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
    Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA
    Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive immunization with human anti-protein D antibodies induced by polysaccharide protein D conjugates protects chinchillas against otitis media after intranasal challenge with Haemophilus influenzae.
    Novotny LA; Jurcisek JA; Godfroid F; Poolman JT; Denoël PA; Bakaletz LO
    Vaccine; 2006 May; 24(22):4804-11. PubMed ID: 16616975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody against Haemophilus influenzae protein D in patients with chronic conditions causing secondary immunodeficiency.
    Hawdon N; Biman B; McCready W; Brigden M; Malik S; Vergidis D; Kisselgoff O; Ulanova M
    Vaccine; 2012 Feb; 30(7):1235-8. PubMed ID: 22230580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines.
    Forsgren A; Riesbeck K; Janson H
    Clin Infect Dis; 2008 Mar; 46(5):726-31. PubMed ID: 18230042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal immunization with outer membrane protein P6 and cholera toxin induces specific sinus mucosal immunity and enhances sinus clearance of nontypeable Haemophilus influenzae.
    Sabirov A; Kodama S; Sabirova N; Mogi G; Suzuki M
    Vaccine; 2004 Aug; 22(23-24):3112-21. PubMed ID: 15297063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
    Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local application of CpG oligodeoxynucleotide enhances nontypeable Haemophilus influenzae-specific mucosal IgA responses in the middle ear.
    Kodama S; Hirano T; Abe N; Suzuki M
    Acta Otolaryngol; 2007 Aug; 127(8):809-15. PubMed ID: 17762989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal coinfection model allows for assessment of protein vaccines against nontypeable Haemophilus influenzae in mice.
    Michel LV; Kaur R; Zavorin M; Pryharski K; Khan MN; LaClair C; O'Neil M; Xu Q; Pichichero ME
    J Med Microbiol; 2018 Oct; 67(10):1527-1532. PubMed ID: 30136923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae.
    Bertot GM; Becker PD; Guzmán CA; Grinstein S
    J Infect Dis; 2004 Apr; 189(7):1304-12. PubMed ID: 15031801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media.
    Sabirov A; Kodama S; Hirano T; Suzuki M; Mogi G
    Infect Immun; 2001 May; 69(5):2964-71. PubMed ID: 11292713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Toll-like receptor 4 in eliciting acquired immune responses against nontypeable Haemophilus influenzae following intranasal immunization with outer membrane protein.
    Hirano T; Kodama S; Moriyama M; Kawano T; Suzuki M
    Int J Pediatr Otorhinolaryngol; 2009 Dec; 73(12):1657-65. PubMed ID: 19765832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of otitis media: now a reality?
    Schuerman L; Borys D; Hoet B; Forsgren A; Prymula R
    Vaccine; 2009 Sep; 27(42):5748-54. PubMed ID: 19666154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the potential of a 48 kDa protein as a vaccine candidate for infection against nontypable Haemophilus influenzae.
    Webb DC; Otczyk DC; Cripps AW
    Vaccine; 2007 May; 25(20):4012-9. PubMed ID: 17379362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal intranasal immunization with outer membrane protein P6 maintains specific antibody level of derived offspring.
    Yamauchi K; Hotomi M; Billal DS; Suzumoto M; Yamanaka N
    Vaccine; 2006 Jun; 24(25):5294-9. PubMed ID: 16697503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
    Kodama S; Hirano T; Noda K; Abe N; Suzuki M
    Vaccine; 2010 Mar; 28(13):2510-6. PubMed ID: 20117272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the immunogenic property of NT H. influenzae protein D with Neisseria meningitidis OMV in BALB/c.
    Behrouzi A; Bouzari S; Siadat SD; Oloomi M; Davari M; Mazaheri H
    J Infect Dev Ctries; 2016 Dec; 10(12):1345-1351. PubMed ID: 28036315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
    Kodama S; Hirano T; Noda K; Umemoto S; Suzuki M
    Vaccine; 2011 Feb; 29(10):1881-90. PubMed ID: 21237276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.